SG/PUT/BRISTOL-MYERS SQUIBB/45/0.1/20.09.24

SG/PUT/BRISTOL-MYERS SQUIBB/45/0.1/20.09.24 Share Price

DE000SY0APC3

Real-time Boerse Frankfurt Warrants 03:31:11 27/06/2024 pm IST
0.35 ^EUR	0.00%

Current month	-27.08%
1 month	-22.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart SG/PUT/BRISTOL-MYERS SQUIBB/45/0.1/20.09.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	27/06	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	26/06	MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees	26/06	MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees	26/06	MT

More news

Quotes 5-day view

Date	Price	Change
27/24/27	0.35	0.00%
26/24/26	0.35	-7.89%
25/24/25	0.38	+2.70%
24/24/24	0.37	-11.90%
21/24/21	0.42	-10.64%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 03:31 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Société Générale
WKN	SY0APC
ISIN	DE000SY0APC3
Date issued	13/05/2024
Strike	45 $
Maturity	20/09/2024 (86 Days)
Parity	10 : 1
Emission price	0.27 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.54 €
Lowest since issue	0.23 €
Spread	0.01 €
Spread %	2.78%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company